Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis.

Authors:
Bryant A; Johnson E; Grayling M; Hiu S; Elattar A and 4 more

Journal:
Am J Ther

Publication Year: 2022

DOI:
10.1097/MJT.0000000000001584

PMCID:
PMC9812425

PMID:
36608071

Journal Information

Full Title: Am J Ther

Abbreviation: Am J Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Therapeutics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors have no conflicts of interest to declare."

Evidence found in paper:

"The authors thank the Cochrane Gynaecological and Neurological Cancer Review Group and the Biostatistics Research Group at Newcastle University for their excellent support. Both Luke Vale and Dawn Craig are funded by the NIHR Applied Research Collaboration for North East and North Cumbria. Luke Vale is also a member of the NIHR Newcastle In Vitro Diagnostics Cooperative."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025